PNC Financial Services Group’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-2
| Closed | -$30 | – | 4697 |
|
2023
Q4 | $30 | Buy |
+2
| New | +$30 | ﹤0.01% | 4589 |
|
2023
Q2 | – | Sell |
-2
| Closed | -$142 | – | 4734 |
|
2023
Q1 | $142 | Hold |
2
| – | – | ﹤0.01% | 4624 |
|
2022
Q4 | $161 | Hold |
2
| – | – | ﹤0.01% | 4656 |
|
2022
Q3 | $0 | Buy |
+2
| New | – | ﹤0.01% | 4439 |
|
2018
Q2 | – | Sell |
-1
| Closed | -$2K | – | 4134 |
|
2018
Q1 | $2K | Hold |
1
| – | – | ﹤0.01% | 4020 |
|
2017
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4138 |
|
2016
Q3 | – | Sell |
-263
| Closed | -$148K | – | 3979 |
|
2016
Q2 | $148K | Buy |
263
+259
| +6,475% | +$146K | ﹤0.01% | 2257 |
|
2016
Q1 | $2K | Hold |
4
| – | – | ﹤0.01% | 4148 |
|
2015
Q4 | $2K | Hold |
4
| – | – | ﹤0.01% | 4135 |
|
2015
Q3 | $3K | Buy |
+4
| New | +$3K | ﹤0.01% | 4121 |
|